Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors

European Journal of Pharmacology

Volumn 594, Issue 1-3, 2008, Pages 84-92

  Gutierrez, Vanessa Pacciari ^a   Konno, Katsuhiro ^b   Chacur, Marucia ^c   Sampaio, Sandra Coccuzzo ^a   Picolo, Gisele ^a   Brigatte, Patricia ^a   Zambelli, Vanessa Olzon ^a   Cury, Yara ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b Center for Applied Toxinology CAT/CEPID   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antinociception; Crotalphine; Gabapentin; Morphine; Neuropathic pain; Opioid receptors

Indexed keywords

ANALGESIC AGENT; CELECOXIB; CROTALPHINE; GABAPENTIN; INDOMETACIN; MORPHINE SULFATE; NALOXONE; OPIATE RECEPTOR; SNAKE VENOM; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HYPERALGESIA; MALE; NERVE COMPRESSION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; CONSTRICTION, PATHOLOGIC; CROTALID VENOMS; HYPERALGESIA; MALE; MOTOR ACTIVITY; PAIN; PAIN THRESHOLD; PEPTIDES; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SCIATIC NEUROPATHY;

EID: 50549095175     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.053     Document Type: Article

References (52)

1. Aird S.D., Kaiser I.I., Lewis R.V., and Kruggel W.G. Rattlesnake presynaptic neurotoxins: primary structure and evolutionary origin of the acidic subunit. Biochemistry 24 (1985) 7054-7058
2. Andoh T., Sugiyama K., Fujita M., Iida Y., Nojima H., Saiki I., and Kuraishi Y. Pharmacological evaluation of morphine and non-opioid analgesic adjuvants in a mouse model of skin cancer pain. Biol. Pharm. Bull. 31 (2008) 520-522
3. Attal N., Jazat F., Kayser V., and Guilbaud G. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain 41 (1990) 235-251
4. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
5. Bon C., Bouchier C., Choumet V., Faure G., Jiang M.S., Lambezat M.P., Radvanyi F., and Saliou B. Crotoxin, half-century of investigations on a phospholipase A2 neurotoxin. Acta Physiol. Pharmacol. Latinoam. 39 (1989) 439-448
6. Brigatte P., Hoffmann F.A., Bernardi M.M., Giorgi R., Fernandes I., Takehara H.A., Barros S.B., Almeida M.G., and Cury Y. Tolerance to the antinociceptive effect of Crotalus durissus terrificus snake venom in mice is mediated by pharmacodynamic mechanisms. Toxicon 39 (2001) 1399-1410
7. Brigatte P., Sampaio S.C., Gutierrez V.P., Guerra J.L., Sinhorini I.L., Curi R., and Cury Y. Walker 256 tumor bearing rats as a model to study cancer pain. J. Pain 8 (2007) 412-421
8. Broadhurst P.L. The place of animal psychology in the development of psychosomatic research. Fortschr. Psychosom. Med. 1 (1960) 63-69
9. Caviedes B.E., and Herranz J.L. [Advances in physiopathology and the treatment of neuropathic pain]. Rev. Neurol. 35 (2002) 1037-1048
10. Chacur M., Longo I., Picolo G., Gutierrez J.M., Lomonte B., Guerra J.L., Teixeira C.F., and Cury Y. Hyperalgesia induced by Asp49 and Lys49 phospholipases A(2) from Bothrops asper snake venom: pharmacological mediation and molecular determinants. Toxicon 41 (2003) 667-678
11. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
12. Chapman V., Suzuki R., Chamarette H.L., Rygh L.J., and Dickenson A.H. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 75 (1998) 261-272
13. Dowdall T., Robinson I., and Meert T.F. Comparison of five different rat models of peripheral nerve injury. Pharmacol. Biochem. Behav. 80 (2005) 93-108
14. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., Bushnell M.C., Farrar J.T., Galer B.S., Haythornthwaite J.A., Hewitt D.J., Loeser J.D., Max M.B., Saltarelli M., Schmader K.E., Stein C., Thompson D., Turk D.C., Wallace M.S., Watkins L.R., and Weinstein S.M. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60 (2003) 1524-1534
15. Erichsen H.K., and Blackburn-Munro G. Pharmacological characterization of the spared nerve injury model of neuropathic pain. Pain 98 (2002) 151-161
16. Faure G., Guillaume J.L., Camoin L., Saliou B., and Bon C. Multiplicity of acidic subunit isoforms of crotoxin, the phospholipase A2 neurotoxin from Crotalus durissus terrificus venom, results from posttranslational modifications. Biochemistry 30 (1991) 8074-8083
17. Gad S., and Weil C. Principles and methods of toxicology. In: Hayer A. (Ed). Statistics for toxinologists (1989), Raven Press Ltd, New York 435-483
18. Giorgi R., Bernardi M.M., and Cury Y. Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom. Toxicon 31 (1993) 1257-1265
19. Hama A.T., and Borsook D. The effect of antinociceptive drugs tested at different times after nerve injury in rats. Anesth. Analg. 101 (2005) 175-179 table of contents
20. Harvey L.O. Efficient estimation of sensory thresholds. Behav. Res. Meth. Instrum. Comput. 18 (1986) 623-632
21. Heimann A.S., Gomes I., Dale C.S., Pagano R.L., Gupta A., de Souza L.L., Luchessi A.D., Castro L.M., Giorgi R., Rioli V., Ferro E.S., and Devi L.A. Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc. Natl. Acad. Sci. U S A 104 (2007) 20588-20593
22. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson J., and Fontana D.J. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324 (1997) 153-160
23. Idanpaan-Heikkila J.J., and Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain 79 (1999) 281-290
24. Joshi S.K., Hernandez G., Mikusa J.P., Zhu C.Z., Zhong C., Salyers A., Wismer C.T., Chandran P., Decker M.W., and Honore P. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity. Neuroscience 143 (2006) 587-596
25. Karaki H., Doi K., Sugano S., Uchiwa H., Sugai R., Murakami U., and Takemoto S. Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp. Biochem. Physiol. C 96 (1990) 367-371
26. Karaki H., Kuwahara M., Sugano S., Doi C., Doi K., Matsumura N., and Shimizu T. Oral administration of peptides derived from bonito bowels decreases blood pressure in spontaneously hypertensive rats by inhibiting angiotensin converting enzyme. Comp. Biochem. Physiol. C 104 (1993) 351-353
27. Konno K., Picolo G., Gutierrez V.P., Brigatte P., Zambelli V.O., Camargo A.C., and Cury Y. Crotalphine, a novel potent analgesic peptide from the venom of the South American rattlesnake Crotalus durissus terrificus. Peptides 29 (2008) 1293-1304
28. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
29. Lee Y.W., Chaplan S.R., and Yaksh T.L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett. 199 (1995) 111-114
30. Meyer-Rosberg K., Kvarnstrom A., Kinnman E., Gordh T., Nordfors L.O., and Kristofferson A. Peripheral neuropathic pain-a multidimensional burden for patients. Eur. J. Pain. 5 (2001) 379-389
31. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., Maier S.F., and Watkins L.R. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 861 (2000) 105-116
32. Milligan E.D., O'Connor K.A., Nguyen K.T., Armstrong C.B., Twining C., Gaykema R.P., Holguin A., Martin D., Maier S.F., and Watkins L.R. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J. Neurosci. 21 (2001) 2808-2819
33. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., Tracey K., Martin D., Maier S.F., and Watkins L.R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23 (2003) 1026-1040
34. Moller K.A., Johansson B., and Berge O.G. Assessing mechanical allodynia in the rat paw with a new electronic algometer. J. Neurosci. Methods 84 (1998) 41-47
35. Nagakura Y., Malkmus S., and Yaksh T.L. Determination of current threshold for paw withdrawal with sine-wave electrical stimulation in rats: effect of drugs and alteration in acute inflammation. Pain 134 (2008) 293-301
36. Pelissier T., Laurido C., Kramer V., Hernandez A., and Paeile C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats. Eur. J. Pharmacol. 477 (2003) 23-28
37. Picolo G., and Cury Y. Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a delta- and kappa-opioid receptor agonist. Life Sci. 75 (2004) 559-573
38. Picolo G., Giorgi R., and Cury Y. Delta-Opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol. 391 (2000) 55-62
39. Picolo G., Cassola A.C., and Cury Y. Activation of peripheral ATP-sensitive K+ channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol. 469 (2003) 57-64
40. Randall L.O., and Selitto J.J. A method for measurement of analgesia activity on inflamed tissue. Arch. Inst. Pharmacodyn. 111 (1957) 209-219
41. Romero-Sandoval E.A., Curros-Criado M.M., Gaitan G., Molina C., and Herrero J.F. Nitroparacetamol (NCX-701) and pain: first in a series of novel analgesics. CNS. Drug Rev. 13 (2007) 279-295
42. Seppo L., Jauhiainen T., Poussa T., and Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77 (2003) 326-330
43. Sipola M., Finckenberg P., Santisteban J., Korpela R., Vapaatalo H., and Nurminen M.L. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 52 (2001) 745-754
44. Stein C., Machelska H., Binder W., and Schafer M. Peripheral opioid analgesia. Curr. Opin. Pharmacol. 1 (2001) 62-65
45. Tal M., and Bennett G.J. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain 57 (1994) 375-382
46. Taylor R.S. Epidemiology of refractory neuropathic pain. Pain Pract. 6 (2006) 22-26
47. Tokuyama S., Inoue M., Fuchigami T., and Ueda H. Lack of tolerance in peripheral opioid analgesia in mice. Life Sci. 62 (1998) 1677-1681
48. Treutwein B., and Strasburger H. Fitting the psychometric function. Percept. Psychophys. 61 (1999) 87-106
49. Vital-Brazil O. Peconhas. In: Corbett C.E. (Ed). Farmacodinâmica (1982), Guanabara Koogan, Rio de Janeiro 1044
50. Walczak J.S., Pichette V., Leblond F., Desbiens K., and Beaulieu P. Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes. J. Neurosci. Res. 83 (2006) 1310-1322
51. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
52. Zollner C., Mousa S.A., Fischer O., Rittner H.L., Shaqura M., Brack A., Shakibaei M., Binder W., Urban F., Stein C., and Schafer M. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J. Clin. Invest. 118 (2008) 1065-1073